Evidence map›Paper›PMID 30127922›Full record

ArticleOncology letters2018

Cell-free culture conditioned medium elicits pancreatic β cell lineage-specific epigenetic reprogramming in mice.

Koichi Kawamoto, Tomofumi Ohashi, Masamitsu Konno, Naohiro Nishida, Jun Koseki, Hidetoshi Matsui, Daisuke Sakai, Toshihiro Kudo, Hidetoshi Eguchi, Taroh Satoh and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Koichi KawamotoDepartment of Gastroenterological Surgery, Osaka University School of Medicine, Suita, Osaka 565-0871, Japan.
Tomofumi OhashiDepartment of Gastroenterological Surgery, Osaka University School of Medicine, Suita, Osaka 565-0871, Japan.
Masamitsu KonnoDepartment of Cancer Frontier Science, Osaka University School of Medicine, Suita, Osaka 565-0871, Japan.
Naohiro NishidaDepartment of Gastroenterological Surgery, Osaka University School of Medicine, Suita, Osaka 565-0871, Japan.
Jun KosekiDepartment of Cancer Profiling Discovery, Osaka University School of Medicine, Suita, Osaka 565-0871, Japan.
Hidetoshi MatsuiDepartment of Mathematical Sciences, Faculty of Mathematics, Kyushu University, Fukuoka 819-0395, Japan.
Daisuke SakaiDepartment of Cancer Frontier Science, Osaka University School of Medicine, Suita, Osaka 565-0871, Japan.
Toshihiro KudoDepartment of Cancer Frontier Science, Osaka University School of Medicine, Suita, Osaka 565-0871, Japan.
Hidetoshi EguchiDepartment of Gastroenterological Surgery, Osaka University School of Medicine, Suita, Osaka 565-0871, Japan.
Taroh SatohDepartment of Cancer Frontier Science, Osaka University School of Medicine, Suita, Osaka 565-0871, Japan.
Yuichiro DokiDepartment of Gastroenterological Surgery, Osaka University School of Medicine, Suita, Osaka 565-0871, Japan.
Masaki MoriDepartment of Gastroenterological Surgery, Osaka University School of Medicine, Suita, Osaka 565-0871, Japan.
Hideshi IshiiDepartment of Cancer Frontier Science, Osaka University School of Medicine, Suita, Osaka 565-0871, Japan.
Osaka University · JPKyushu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are several obstacles to overcome prior to achieving cellular reprogramming of pancreatic β cells

Indexed as

conditioned mediumepigenetic reprogrammingpancreatic β cell

Identifiers

PMID30127922
PMCPMC6096232
OpenAlexW2808745369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.